Studies of gammaherpesvirus infection and host response
by Buchingham, Erin M., Ph.D., UNIVERSITY OF COLORADO HEALTH SCIENCES CENTER, 2007, 212 pages; 3289825

Abstract:

Gammaherpesviruses cause a lifelong infection and are associated with lymphoproliferative disease and chronic inflammatory disease. Gammaherpesvirsues are extremely host species specific, making it difficult to study the human viruses in vivo. Mouse gammaherpesvirus 68 (γHV68) provides an excellent model to study this family of viruses due to their common biology, genome organization, and associated pathologies. I investigated the host response to gammaherpesvirus infection, and created tools to study γHV68 infection in vitro and in vivo.

I used BAC mutagenesis to construct recombinant viruses from which all future recombinants at the v-cyclin locus will be made. The marked viruses were constructed and will serve as a framework for the construction of future marked viruses to track viral infection and gene expression. I investigated the host immune response to γHV68 infection. I found evidence suggestive of continued antigen presentation from infected cells during latency, likely from sporadic reactivation events, as seen by (1) increased number and percentage of T cells, (2) increased T cell-produced cytokines, and (3) upregulation of activated macrophages in the peritoneal cavity. The differences found in the magnitude of the response in both spleen and peritoneal cavity (sites of viral latency) in IFNγR-/- mice compared to BL/6 mice support the hypothesis that the immune response in mice that develop chronic disease after γHV68 infection is different than in mice that remain healthy and control infection, and that the v-cyclin is a factor that links reactivation and chronic disease via the host immune response.

I also investigated the role of the p19Arf tumor suppressor protein in γHV68 infection, which appeared to play no significant role in replication of the virus in vitro or in reactivation from latency, but was induced during γHV68 infection in vitro and in vivo. These studies also revealed a population of immature peritoneal macrophages elicited by inflammation, in which p 19Arf was induced and appears to play an important role in their maturation and terminal differentiation. These studies are valuable in elucidating the host response to gammaherpesvirus infection, and may have revealed an important gene in the regulation of macrophage differentiation in inflammatory responses.

 
AdviserLinda F. van@Dyk
SchoolUNIVERSITY OF COLORADO HEALTH SCIENCES CENTER
SourceDAI/B 68-11, p. , Feb 2008
Source TypeDissertation
SubjectsMicrobiology; Virology; Immunology
Publication Number3289825
Adobe PDF Access the complete dissertation:
 

» Find an electronic copy at your library.
  Use the link below to access a full citation record of this graduate work:
  http://gateway.proquest.com/openurl%3furl_ver=Z39.88-2004%26res_dat=xri:pqdiss%26rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation%26rft_dat=xri:pqdiss:3289825
  If your library subscribes to the ProQuest Dissertations & Theses (PQDT) database, you may be entitled to a free electronic version of this graduate work. If not, you will have the option to purchase one, and access a 24 page preview for free (if available).

About ProQuest Dissertations & Theses
With over 2.3 million records, the ProQuest Dissertations & Theses (PQDT) database is the most comprehensive collection of dissertations and theses in the world. It is the database of record for graduate research.

The database includes citations of graduate works ranging from the first U.S. dissertation, accepted in 1861, to those accepted as recently as last semester. Of the 2.3 million graduate works included in the database, ProQuest offers more than 1.9 million in full text formats. Of those, over 860,000 are available in PDF format. More than 60,000 dissertations and theses are added to the database each year.

If you have questions, please feel free to visit the ProQuest Web site - http://www.proquest.com - or call ProQuest Hotline Customer Support at 1-800-521-3042.